Cyclezyme AbNGM: CYCLE

CYCLE: Cyclezyme advances commercialization with new partnerships, improved results, and solid funding

· Issued by Cyclezyme Ab

Cyclezyme reported increased revenue and reduced losses in Q1 2025, secured new strategic partnerships, and completed a share issue to fund operations for up to 24 months, positioning itself to benefit from EU recycling mandates and growing market demand.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Cyclezyme Ab

All Cyclezyme Ab news releases